Welcome to Dividends Inside
Welcome to Dividends Inside!

The platform is currently in beta, so some features and data may still change as we improve the service. If you have questions, feedback, or run into anything unexpected, please contact us at info@dividendsinside.com.

Aluminum Corp of China Ltd

ACH
$2.67 (- $0.13 - 4.64%)
Last updated: 2026-05-20 21:23 UTC
ACH Metrics
Exchange
🇺🇸 NYSE XNYS
New York Stock Exchange, Inc.United StatesAmerica/New_York
SectorHealthcare
IndustryMedical Distribution
ISINUS6907321029
Market Price2.67
Dividend Yield N/A
Dividend Growth
1YN/A
3YN/A
5Y -67.99%
10Y -9.77%
Annual Dividend N/A
Latest Payout ($)0.0
Latest Payout Date2020-12-14
Dividend FrequencyNone
P/E RatioN/A
EPSN/A
Market Cap$184.9M
Book Value-5.56
Price to Book-0.43
Beta0.1
52w High9.55
52w Low1.84
Next Earnings DateN/A
About the Company
Accendra Health, Inc. is a leading nationwide provider of products, technology, and services that support health beyond the hospital for millions of people annually. The company connects patients, providers, and insurers through innovative solutions designed to promote better health outcomes and enhance quality of life for individuals managing chronic and complex conditions. Specializing in home-based care, Accendra Health offers a broad portfolio of essentials covering diabetes management, sleep health, wound care, respiratory support, urology, and ostomy needs. Backed by the expertise of its flagship Apria and Byram brands, it reimagines post-hospital care delivery with a focus on accessibility and efficacy. Founded in 1882 and headquartered in Richmond, Virginia, the company employs approximately 23,200 people and operates within the healthcare sector, particularly in health care distribution and patient direct services. Following a strategic divestiture of its former Products & Healthcare Services business at the end of 2025, Accendra Health continues to play a pivotal role in advancing home health solutions across the United States.
Price History
Latest News for ACH
Owens & Minor Names Chief Operating Officer
Owens & Minor, a global healthcare solutions company providing essential products, services and technology solutions that support care delivery in leading hospitals, health systems and research centers around the world, today announced Marc Rottink as Chief Operating Officer (COO) of Owens & Minor, effective immediately.
Accendra Health Inc (ACH) Q1 2026 Earnings Call Highlights: Navigating Revenue Declines and ...
Despite a challenging quarter marked by a revenue decline, Accendra Health Inc (ACH) focuses on debt reduction and growth in key categories like sleep therapy and home respiratory care.
Accendra Health (ACH) Q1 2026 Earnings Transcript
The press release, along with the first quarter 2026 supplemental slides, which we will refer to throughout the call are posted in the Investor Relations section of our website. Please note that during the call, we will make forward-looking statements that reflect the current views of sundra Health about our business, financial performance and future events.
Accendra Health (ACH) Shares Jump After First-Quarter Earnings Beat
Accendra Health, Inc. (NYSE:ACH) shares surged nearly 10% in premarket trading on Monday after the home-based healthcare company reported first-quarter 2026 earnings that came in ahead of analyst expectations.
Accendra Health Reports First Quarter 2026 Financial Results and Announces Comprehensive Balance Sheet Optimization Transaction
RICHMOND, Va., May 11, 2026--Accendra Health, Inc. (NYSE: ACH) today reported financial results for the first quarter ended March 31, 2026, and announced a more than $1.5 billion comprehensive balance sheet optimization transaction with commitments from existing creditors that will strengthen the balance sheet, significantly extend maturities and reduce total leverage. Unless otherwise noted, the results herein reflect the Company’s continuing operations, which represent what was previously the
WAT Q1 Earnings Beat Estimates, BD Acquisition Aids Revenues
Waters crushes Q1 2026 estimates as revenues surge 91.5%; newly acquired BD units top targets early, and 2026 guidance moves higher.